Secarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics Media Outreach|28/05/2024oleh RRINEWSS Partnership expands spectrum of Secarna’s capabilities for the development of targeted ASOs
